Altamira Therapeutics Competitors and Similar CompaniesClear all
Altamira Therapeutics's competitors and similar companies include UCB, EMS Pharma, Livzon Pharmaceutical Group and Cipla.
 Altamira Therapeutics Altamira Therapeutics (formerly known as Auris Medical) is a biopharmaceutical company that provides therapeutics for medical needs in neurotology and central nervous system disorders. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | |
Founding Date | Founding Date 1998 | Founding Date 1928 | Founding Date 1964 | Founding Date 1985 | Founding Date 1935 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Basel, CH HQ Hamilton, BM Dublin, IE Chicago, US Dover, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations BR HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 8 | Employees 9,052 | Employees 12,7441% increase | Employees 9,067 | Employees 27,764 |
Valuation ($) | Valuation ($) 39.2 m | Valuation ($) 34.3 b | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit $75k (FY, 2024) | Gross profit €7.2b (FY, 2025) | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit ₹195b (FY, 2026) |
Net income | Net income ($8.5m) (FY, 2024) | Net income €1.6b (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) | Net income ₹38.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company